Piritrexim
Product Specifications
CAS Number
72732-56-0
Target
DHFR
Related Pathways
Cell Cycle/Checkpoint, Metabolism, DNA Damage/DNA Repair
Purity
>99.99%
Bioactivity
Piritrexim (BW 301U) is an orally available fat-soluble dihydrofolate reductase inhibitor with pulmonary toxicity used in the study of uroepithelial carcinoma and metastatic breast cancer.
Smiles
CC=1C2=C(N=CC1CC3=C(OC)C=CC(OC)=C3)N=C(N)N=C2N
Molecular Formula
C17H19N5O2
Molecular Weight
325.37
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
122946-PE 100 µL
ACVR1B (Activin Receptor Type-1B, Activin Receptor Type IB, Serine/Threonine-protein Kinase Receptor R2, SKR2, Activin Receptor-like Kinase 4, ACVRLK4, ALK4) (PE)
Sign In for Pricing
View Details 